Tumor-induced lymph node alterations detected by MRI lymphography using gadolinium nanoparticles.
Contrast-enhanced MRI lymphography shows potential to identify alterations in lymph drainage through lymph nodes (LNs) in cancer and other diseases. MRI studies have typically used low molecular weight gadolinium contrast agents, however larger gadolinium-loaded nanoparticles possess characteristics that could improve the specificity and sensitivity of lymphography. The performance of three gadolinium contrast agents with different sizes and properties was compared by 3T MRI after subcutaneous injection. Mice bearing B16-F10 melanoma footpad tumors were imaged to assess tumor-induced alterations in lymph drainage through tumor-draining popliteal and inguinal LNs versus contralateral uninvolved drainage. Gadolinium lipid nanoparticles were able to identify tumor-induced alterations in contrast agent drainage into the popliteal LN, while lower molecular weight or albumin-binding gadolinium agents were less effective. All of the contrast agents distributed in foci around the cortex and medulla of tumor-draining popliteal LNs, while they were restricted to the cortex of non-draining LNs. Surprisingly, second-tier tumor-draining inguinal LNs exhibited reduced uptake, indicating that tumors can also divert LN drainage. These characteristics of tumor-induced lymph drainage could be useful for diagnosis of LN pathology in cancer and other diseases. The preferential uptake of nanoparticle contrasts into tumor-draining LNs could also allow selective targeting of therapies to tumor-draining LNs.
Seattle Cancer Care Alliance, Seattle WA USA.|Department of Radiology, University of Washington, Seattle WA USA.
S C
SC
Partridge
Department of Biostatistics, University of Pittsburgh, Pittsburgh, PA.
B F
BF
Kurland
Seattle Cancer Care Alliance, Seattle WA USA.|Department of Radiology, University of Washington, Seattle WA USA.
C-L
CL
Liu
Department of Pharmaceutics, University of Washington, Seattle WA USA.
R J Y
RJ
Ho
Department of Comparative Medicine, Seattle WA USA.|Fred Hutchinson Cancer Research Center, Seattle WA USA.
A
A
Ruddell
D000818:Animals; D003287:Contrast Media / Q000737:chemistry*; D004195:Disease Models, Animal; D005682:Gadolinium / Q000737:chemistry*; D008198:Lymph Nodes / Q000503:physiopathology*; D008207:Lymphatic Metastasis / Q000175:diagnosis*; D008220:Lymphography / Q000379:methods*; D008279:Magnetic Resonance Imaging / Q000379:methods; D008546:Melanoma, Experimental / Q000175:diagnosis; D053768:Metal Nanoparticles / Q000737:chemistry*; D051379:Mice; D008810:Mice, Inbred C57BL; D012680:Sensitivity and Specificity
D003287:Contrast Media; D005682:Gadolinium